Newron Pharmaceuticals S.p.A. (FRA:NP5)
Germany
· Delayed Price · Currency is EUR 7.53
+0.02 (0.27%)
Last updated: Apr 28, 2025
Newron Pharmaceuticals Revenue
In the year 2024, Newron Pharmaceuticals had annual revenue of 51.39M EUR with 467.41% growth. Newron Pharmaceuticals had revenue of 47.98M in the half year ending December 31, 2024, with 1,370.07% growth.
Revenue
51.39M
Revenue Growth
+467.41%
P/S Ratio
2.96
Revenue / Employee
2.34M
Employees
22
Market Cap
152.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51.39M | 42.33M | 467.41% |
| Dec 31, 2023 | 9.06M | 2.96M | 48.62% |
| Dec 31, 2022 | 6.09M | 332.00K | 5.76% |
| Dec 31, 2021 | 5.76M | 504.00K | 9.59% |
| Dec 31, 2020 | 5.26M | -1.78M | -25.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 76.54B |
| Deutsche Telekom AG | 118.43B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 9.75B |
| Siemens Energy AG | 35.76B |
| Merck KGaA | 21.16B |